This program offers advanced training in nanomedicine and immunopharmacology, focusing on neutrophil-targeted therapies for diseases such as E. coli-induced sepsis . The program has a duration of 6 months and includes hands-on laboratory research, seminars, and mentorship. It is open to students and early-career researchers in pharmacy, biomedical sciences, or related fields with basic English proficiency. Registration and accommodation fees will be covered, reducing the financial burden for participants. Participants are expected to actively engage in research activities and present their findings at the end of the program.